4D Molecular Therapeutics

4D Molecular Therapeutics designs, develops and commercializes transformative gene therapeutic products for serious unmet medical conditions.

Est. revenue: $20M–$50M
Total raised: $902M
Latest round: Post-IPO Debt
Employees: 217

Claim profile

Funding & revenue at 4D Molecular Therapeutics

How well capitalized the business is — useful context before you scope a fractional engagement or negotiate a rate.

Estimated annual revenue

$20M–$50M

Modeled range, not company-reported

Total capital raised

$902M

20 known investors

Latest round

Post-IPO Debt · $200M

Jun 2026

Publicly traded

FDMT, 4DMOLECULARTHERAPEUTICS

IPO Dec 2020

Investors

Amzak Health InvestorsArrowMark PartnersBerkeley Catalyst Fund (BCF)Biotechnology Value FundCasdin CapitalChiesi VenturesCureDuchenne VenturesCystic Fibrosis FoundationHercules CapitalJanus Henderson InvestorsLongevity Vision FundMirae AssetMiraeAsset Financial GroupOctagon Capital AdvisorsPappas CapitalPerceptive AdvisorsPfizer Venture InvestmentsQUAD Investment ManagementRidgeback CapitalViking Global Investors

Growth signals

How fast 4D Molecular Therapeutics is adding people, roles, and audience.

Employees

217

Reported band 51-200

LinkedIn followers

23.1K

+22.5% year over year

Headcount change

MoM: -0.5%; -1 people
QoQ: +0.5%; +1 people
6mo: +4.3%; +9 people
YoY: +6.4%; +13 people
2yr: -10.7%; -26 people

Team composition

Where 4D Molecular Therapeutics concentrates its people — a read on which function a fractional leader would plug into.

By function

Research5827%
Business Development2512%
Healthcare Services2210%
Operations199%
Quality Assurance126%
Human Resources115%
Information Technology115%
Legal73%

By region

United States209
California, United States142
San Francisco Bay Area133
Emeryville, CA21
San Francisco, CA20
Oakland, CA13

Inside 4D Molecular Therapeutics

What the business focuses on, where it operates, and how employees rate it.

Specialties

Gene TherapyAdeno-Associated VirusBiotechnologyRare DiseasesClinicalLabClinical TrialsScienceretinacystic fibrosisgenetic medicineophthalmology

Markets

NASDAQ

Competitors

Companies in the same market as 4D Molecular Therapeutics.

http://www.newperspectives-us.comhttps://www.mtem.com/https://www.4tuneengineering.comhttps://www.daresburyproteins.co.ukhttps://enablebiotech.com/http://www.mbftherapeutics.comhttp://www.pdsbiotech.com/https://haldatherapeutics.com/https://www.xmddiagnostics.comhttps://diversebiotech.comhttps://atlasmolecularpharma.com/http://www.dtsbr.comhttp://www.jmdna.com/http://www.cureduchenne.orghttps://www.4dpath.com/https://bioivt.com/